insights_auto
Why is KAPA down 5.62%?
Dive Deeperchevron_right
KAPA:NYSEAMERICAN
Kairos Pharma Ltd
$0.45
arrow_downward
-5.62%(-0.027) 1D
$0.46
arrow_upward
+2.51% (+0.011)bedtimeAfter hours
Closed: Nov 13, 4:00:00 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for KAPA...
Open
$0.50
High
$0.50
Low
$0.45
Mkt. cap
1.54M
Avg. vol.
677.84K
Volume
12.57K
52-wk high
$7.28
52-wk low
$0.42
EPS
-$1.95
Shares outstanding
3.38M
No. of employees
3
Open
$0.50
High
$0.50
Low
$0.45
Mkt. cap
1.54M
Avg. vol.
677.84K
Volume
12.57K
52-wk high
$7.28
52-wk low
$0.42
EPS
-$1.95
Shares outstanding
3.38M
No. of employees
3
News stories
From web sources and news partners
BigGo Finance
·
40 minutes ago
Goldman Sachs Sets 8,700 S&P 500 Target for 2027, Sees 14% Upside as AI Capex Peaks
TheStreet
·
1 hour ago
Goldman Sachs reset S&P 500 price target for 2027
TradingKey
·
11 hours ago
S&P 500 Forecast: Index Poised to Retest Record High in November After 500-Point Pullback, Biggest Daily Gain in Nearly Seven Months
StoneX
·
2 days ago
S&P 500, Nasdaq 100 Claw Back But NVDA Cloud Looms Overhead
About Kairos Pharma Ltd
CEO-
Employees3
Founded2013
HeadquartersLos Angeles, California, United States
SectorHealth Care
IndustryBiotechnology
Websitekairospharma.com